Related Experiment Videos
Antimetastatic effects of maleic anhydride-divinyl ether in rats with mammary adenocarcinoma
Abstract:
Effects of maleic anhydride-divinyl ether (MVE-2) on lymph node and lung metastases were studied in rats transplanted with a syngeneic mammary adenocarcinoma. Subcutaneous treatment with MVE-2 was administered according to various schedules, with or without surgical removal of the primary tumor. A significant reduction in size and/or incidence of lymph node metastases was observed, although no effect on the primary tumor was noted. Histologic evidence of degeneration of metastatic tumor cells, which were surrounded by lymphocytes and a characteristic focal histiocytosis, was present in the regional lymph nodes. The number of lung metastases resulting from iv injection of tumor cells was also significantly reduced following iv injection of MVE-2.
Insights
Maleic anhydride-divinyl ether (MVE-2) effectively reduced lymph node and lung metastases in a rat breast cancer model. The compound showed no effect on the primary tumor but induced tumor cell degeneration in lymph nodes.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Metastasis is a primary cause of cancer-related mortality.
- Developing effective anti-metastatic agents is crucial for improving patient outcomes.
- Maleic anhydride-divinyl ether (MVE-2) is a synthetic polymer with potential immunomodulatory and anti-tumor properties.
Purpose of the Study:
- To investigate the efficacy of maleic anhydride-divinyl ether (MVE-2) in preventing or reducing lymph node and lung metastasis.
- To evaluate the effects of MVE-2 on primary tumor growth and metastatic tumor cell histology.
Main Methods:
- Syngeneic mammary adenocarcinoma cells were transplanted into rats.
- Rats were treated with MVE-2 subcutaneously or intravenously according to various schedules.
- Primary tumors were surgically removed in some groups.
- Tumor size, incidence of lymph node and lung metastases, and histological features were assessed.
Main Results:
- MVE-2 treatment significantly reduced the size and/or incidence of lymph node metastases.
- No significant effect of MVE-2 on the primary tumor was observed.
- Histological examination revealed degeneration of metastatic tumor cells in lymph nodes, accompanied by lymphocytic infiltration and histiocytosis.
- Intravenous MVE-2 administration significantly reduced the number of lung metastases after intravenous tumor cell injection.
Conclusions:
- MVE-2 demonstrates significant anti-metastatic activity against lymph node and lung metastasis in a rat breast cancer model.
- MVE-2 induces tumor cell degeneration and elicits an immune response in metastatic sites.
- Further research into MVE-2 as a potential therapeutic agent for metastasis is warranted.